Accelerate to discover

Homepage>Discover>Use of the iQue Screener as a versatile tool for in-vitro immunogenicity and immunotoxicity risk assessment

Back to filter

Oct 28, 2020

Do you think that centrifuging cells at 500 x g is not going to cause issues? Moreover, sample prep involving...

Sep 30, 2020

Extracellular vesicles (EVs) are lipid spheres released from cells. EVs express proteins and contain cargo that pertain...

Sep 25, 2020

Pancreatic ductaladenocarcinoma (PDA) is the third leading cause of cancer related death in the United States,...

Aug 20, 2020

Hyperpolarized 129Xe MR has been proven to be a powerful tool to evaluate the pulmonary function and has been widely...

Nov 23, 2020

Aug 11, 2020

2015 marked the first ever translation of hyperpolarized gas MRI to diagnostic clinical practice. Research at the...

Jul 29, 2020

Technology allowing evaluation of live animals repeatedly is indispensable to gain better insight into the dynamics of...

Jul 17, 2020

After a short introduction on the physio-pathological roles of platelets and the importance of their cell adhesion...

Nov 23, 2020

Jul 14, 2020

Watch the recorded webinar on PET/MR, driven by Peter Caravan at MGH for the application part, during which the launch...

Use of the iQue Screener as a versatile tool for in-vitro immunogenicity and immunotoxicity risk assessment

Sep 29, 2015

Brecht Hoedemaekers, ImmunXperts

November 12th, 4pm BST

REGISTER NOW

Webinar

Get more info

Head of application support

Riccardo

Pasculli

+420 731 127 717

pasculli@accela.eu

Send Message

Brand profile

IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.